Kaliki Swathi, Maniar Arpita, Patel Anamika, Palkonda Vijay Anand Reddy, Mohamed Ashik
The Operation Eyesight Universal Institute for Eye Cancer (SK, AM, AP, VARP), L V Prasad Eye Institute, Hyderabad, 500034, India.
Ophthalmic Biophysics (AM), L V Prasad Eye Institute, Hyderabad, India.
Int Ophthalmol. 2020 Jan;40(1):99-107. doi: 10.1007/s10792-019-01155-z. Epub 2019 Aug 23.
To compare the clinical presentation and outcomes of retinoblastoma (RB) based on age at presentation.
Retrospective comparative study of 1940 eyes of 1450 children with RB.
Presentation of RB with enlarged eyeball and eyelid swelling (2% and < 1% in ≤ 1 year, 4% and 2% in > 1-2 years, 7% and 2% in > 2-3 years, and 12% and 4% in > 3 years; p < 0.0001 and p = 0.05, respectively) is more common with increasing age. Based on the 8th edition of American Joint Committee Classification, T1 is more common in children younger than 1 year (27%), while T4 is more common in children > 3 years of age (20%) (p < 0.0001). Kaplan-Meier (KM) estimate at 1 and 5 years for globe salvage was 64% and 58% in children ≤ 1 year of age versus 30% and 20% in children > 3 years, respectively [Hazard ratio (HR) = 2.48; p < 0.0001], and KM estimate at 1 and 5 years for life salvage was 99% and 97% in children ≤ 1 year of age versus 89% and 78% in children older than 3 years, respectively (HR = 7.65; p < 0.0001).
Uncommon clinical features of RB including enlarged eyeball and eyelid swelling are more common with increasing age. Younger age at presentation with RB is associated with better prognosis including higher chances of life and globe salvage.
根据就诊年龄比较视网膜母细胞瘤(RB)的临床表现和预后。
对1450例患有RB的儿童的1940只眼睛进行回顾性比较研究。
随着年龄增长,RB表现为眼球增大和眼睑肿胀更为常见(1岁及以下分别为2%和<1%,1至2岁以上分别为4%和2%,2至3岁以上分别为7%和2%,3岁以上分别为12%和4%;p<0.0001和p=0.05)。根据美国联合委员会第8版分类,T1在1岁以下儿童中更为常见(27%),而T4在3岁以上儿童中更为常见(20%)(p<0.0001)。1岁及以下儿童眼球挽救的1年和5年Kaplan-Meier(KM)估计值分别为64%和58%,而3岁以上儿童分别为30%和20%[风险比(HR)=2.48;p<0.0001],1岁及以下儿童生命挽救的1年和5年KM估计值分别为99%和97%,而3岁以上儿童分别为89%和78%(HR=7.65;p<0.0001)。
RB不常见的临床特征包括眼球增大和眼睑肿胀随着年龄增长更为常见。RB就诊时年龄较小与较好的预后相关,包括更高的生命和眼球挽救几率。